Protective effects of surfactant protein D treatment in 1,3-β-glucan-modulated allergic inflammation

Am J Physiol Lung Cell Mol Physiol. 2015 Dec 1;309(11):L1333-43. doi: 10.1152/ajplung.00090.2015. Epub 2015 Oct 2.

Abstract

Surfactant protein D (SP-D) is a pulmonary collectin important in lung immunity. SP-D-deficient mice (Sftpd(-/-)) are reported to be susceptible to ovalbumin (OVA)- and fungal allergen-induced pulmonary inflammation, while treatment with exogenous SP-D has therapeutic effects in such disease models. β-Glucans are a diverse group of polysaccharides previously suggested to serve as fungal ligands for SP-D. We set out to investigate if SP-D could interact with 1,3-β-glucan and attenuate allergic pulmonary inflammation in the presence of 1,3-β-glucan. Allergic airway disease was induced in Sftpd(-/-) and Sftpd(+/+) mice by OVA sensitization and subsequent challenge with OVA, 1,3-β-glucan, or OVA/1,3-β-glucan together. Mice in the combined treatment group were further treated with a high dose of recombinant fragment of human SP-D (rfhSP-D). We demonstrated direct interaction between SP-D and 1,3-β-glucan. OVA-induced mucous cell metaplasia was increased in Sftpd(-/-) mice, supporting previously reported protective effects of endogenous SP-D in allergy. OVA-induced parenchymal CCL11 levels and eosinophilic infiltration in bronchoalveolar lavage were unaffected by 1,3-β-glucan, but were reversed with rfhSP-D treatment. 1,3-β-Glucan treatment did, however, induce pulmonary neutrophilic infiltration and increased TNF-α levels in bronchoalveolar lavage, independently of OVA-induced allergy. This infiltration was also reversed by treatment with rfhSP-D. 1,3-β-Glucan reduced OVA-induced mucous cell metaplasia, T helper 2 cytokines, and IFN-γ production. rfhSP-D treatment further reduced mucous metaplasia and T helper 2 cytokine secretion to background levels. In summary, rfhSP-D treatment resulted in attenuation of both allergic inflammation and 1,3-β-glucan-mediated neutrophilic inflammation. Our data suggest that treatment with high-dose SP-D protects from mold-induced exacerbations of allergic asthma.

Keywords: 1,3-β-glucan; allergic asthma; mouse model; ovalbumin; surfactant protein D.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chemokine CCL11 / metabolism
  • Cytokines / metabolism
  • Female
  • Humans
  • Hypersensitivity / complications*
  • Hypersensitivity / drug therapy*
  • Hypersensitivity / pathology
  • Immunoglobulin E / metabolism
  • Inflammation / complications*
  • Inflammation / drug therapy*
  • Inflammation / pathology
  • Ligands
  • Metaplasia
  • Mice, Inbred C57BL
  • Microbiota / drug effects
  • Ovalbumin
  • Protective Agents / pharmacology
  • Protective Agents / therapeutic use*
  • Proteoglycans
  • Pulmonary Alveoli / drug effects
  • Pulmonary Alveoli / pathology
  • Pulmonary Surfactant-Associated Protein D / pharmacology
  • Pulmonary Surfactant-Associated Protein D / therapeutic use*
  • Respiratory Hypersensitivity / complications
  • beta-Glucans / metabolism*

Substances

  • Ccl11 protein, mouse
  • Chemokine CCL11
  • Cytokines
  • Ligands
  • Protective Agents
  • Proteoglycans
  • Pulmonary Surfactant-Associated Protein D
  • beta-Glucans
  • Immunoglobulin E
  • polysaccharide-K
  • Ovalbumin